Skip to content

Price / sales at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
10.2×
ICU Medical logo
ICU MedicalICUI
1.5×+0.1×
Universal Health Services logo
Universal Health ServicesUHS
0.6×-0.1×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
1.5×-0.3×
HCA Healthcare logo
HCA HealthcareHCA
1.4×+0.2×

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.96B+42.9%
Enterprise value$2.38B+22.3%
P/E11.3×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Calculated from Pediatrix Medical Group’s reported figures.

Based on the most recent quarter.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's price / sales?
Pediatrix Medical Group (MD) reported price / sales of 0.9× in Q1 2026.
How has Pediatrix Medical Group's price / sales changed year-over-year?
Pediatrix Medical Group's price / sales increased by 46.2% year-over-year, from 0.6× to 0.9×.
What is the long-term trend for Pediatrix Medical Group's price / sales?
Over 5 years (2020 to 2025), Pediatrix Medical Group's price / sales has grown at a -4.3% compound annual growth rate (CAGR), from 1.2× to 1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.